AVNS — AVANOS MEDICAL

Ownership history in Foundry Partners, LLC  ·  12 quarters on record

This page tracks every 13F SEC filing in which Foundry Partners, LLC reported a position in AVANOS MEDICAL (AVNS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.5% (2023 Q4)
Avg. % of fund
0.16%
First filed
2022 Q1
Last filed
2024 Q4
Quarters held
12
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2024 Q4 REDUCED 119,870 -43,160 -26.5% 0.10% $1.9M $15.92
2024 Q3 ADDED 163,030 +1,800 +1.1% 0.19% $3.9M $24.03
2024 Q2 REDUCED 161,230 -2,025 -1.2% 0.17% $3.2M $19.92
2024 Q1 REDUCED 163,255 -207,774 -56.0% 0.17% $3.3M $19.91
8 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    AVNS price (monthly, adj. close)

Other funds also holding AVNS

As of 2025 Q4 — sorted by position size

KESTREL INVESTMENT MANAGEMENT CORP 3Y 7Y 0.9% NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 3Y 7Y 0.7% SummerHaven Investment Management, LLC 3Y 0.44% ARMISTICE CAPITAL, LLC 3Y 7Y 0.43% Williams & Novak, LLC 0.29% PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 3Y 7Y 0.18% VIRTUS ADVISERS, LLC 3Y 7Y 0.1% FOX RUN MANAGEMENT, L.L.C. 3Y 7Y 0.09% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.07% AXQ CAPITAL, LP 3Y 0.07%
← Back to Foundry Partners, LLC Holdings